VALHI INC

Insider Trading & Executive Data

VHI
NYSE
Basic Materials
Chemicals

Start Free Trial

Get the full insider signal for VHI

7 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
7
0 in last 30 days
Buy / Sell (1Y)
7/0
Acquisitions / Dispositions
Unique Insiders (1Y)
7
Active in past year
Insider Positions
6
Current holdings
Position Status
6/0
Active / Exited
Institutional Holders
59
Latest quarter
Board Members
23

Compensation & Governance

Avg Total Compensation
$2.3M
Latest year: 2024
Executives Covered
8
Comp records available
Form 8-K Events (1Y)
1
Personnel Changes (1Y)
1
Bonus Plan Events (1Y)
0
Organization Changes (1Y)
0
Board Appointments (1Y)
1
Board Departures (1Y)
0

Restricted Sales

Form 144 Filings (1Y)
0
Form 144 Insiders (1Y)
0
Planned Sale Shares (1Y)
0
Planned Sale Value (1Y)
$0.00
Price
$14.13
Market Cap
$395.4M
Volume
23,267
EPS
$-0.78
Revenue
$503.5M
Employees
2.5K
About VALHI INC

Company Overview

Valhi, Inc. is a publicly traded holding company whose primary operations are conducted through Kronos (Chemicals), CompX (Component Products) and Basic Management/LandWell (Real Estate). Kronos is a leading global producer of titanium dioxide (TiO2) pigments (535,000 metric tons produced in 2024; capacity utilization ~96% in 2024) with chloride and sulfate plants across Europe, North America and Norway/Louisiana, and it invested roughly $14M in R&D in 2024. The company’s 2024 recovery (net income $108.0M vs. a loss in 2023) was driven by higher Chemicals volumes and a one-time remeasurement gain from the July 2024 LPC acquisition, while 2025 YTD results show weaker Chemicals operating income and lower utilization (Q2 2025 utilization ~81%) that have increased leverage/interest pressures. Key ongoing exposures are TiO2 cyclicality tied to GDP, feedstock and energy cost volatility, environmental and regulatory scrutiny (including EU TiO2 classification risk), tariff uncertainty, customer concentration, and material debt-service requirements.

Executive Compensation Practices

Given Valhi’s business mix, executive incentive pay is likely weighted to near-term operational metrics for Kronos (operating income, TiO2 volumes, capacity utilization and gross margin) plus cash-generation measures (operating cash flow, free cash flow and maintenance of covenant ratios) because cash and debt service rose after the LPC acquisition. Long-term pay is likely equity‑based (restricted stock, performance shares or options) tied to EPS/TSR or ROIC to align management with shareholder value and to reward successful integration of LPC and sustained margin recovery; R&D progress, safety performance and environmental compliance metrics may be incorporated as modifiers. Compensation committees commonly exclude non-recurring items (e.g., the LPC remeasurement gain or one-time settlement income) from incentive calculations, so watch plan definitions for such carve-outs. The substantial unionized workforce, pension and environmental liabilities also constrain cost‑reduction levers and can shape severance/retention arrangements and long‑term incentive vesting schedules.

Insider Trading Considerations

Insider trading at Valhi may cluster around discrete, material events: quarterly earnings, the LPC acquisition/related financings, environmental settlement announcements, and tariff or regulatory decisions affecting TiO2 classification — all of which can rapidly change outlook and stock price. Because 2024 produced large one‑time cash/marketable security increases and 2025 showed deteriorating cash flow and higher leverage, insiders may opportunistically sell after cash infusions or buy when Chemicals weakness depresses the share price; conversely, persistent covenant risk can create motivations to limit public sales. Expect typical corporate controls: blackout periods around earnings and M&A, use of Rule 10b5‑1 plans, and potential internal restrictions tied to covenant compliance or material nonpublic regulatory developments (environmental/regulatory outcomes are especially sensitive). Monitor Form 4s for option exercises, 10b5‑1 plan trades, large affiliate transactions and any deviation from historical sale patterns that could signal management views on near‑term prospects.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for VALHI INC and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime